← Open Payments lookup

SHELLY FOWLER: Open Payments

NPI 1598954208 · LEEDS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,202 in 60 payments from 13 companies in 2025. Trend: 2023 $2,889 · 2024 $2,822 · 2025 $1,202

Food & beverage: $1,202
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP14$344
Regeneron Healthcare Solutions, Inc.14$250
GlaxoSmithKline, LLC.11$161
Amgen Inc.5$110
GENZYME CORPORATION3$61
Takeda Pharmaceuticals U.S.A., Inc.2$58
GC Biopharma USA, Inc.2$49
PFIZER INC.3$49
LEO Pharma Inc.2$46
Pharming Healthcare, Inc.1$28

Products named: DUPIXENT, FASENRA, TEZSPIRE, TRELEGY ELLIPTA, AIRSUPRA, TAKHZYRO, ALYGLO, CIBINQO.

Industry payments across MA — which companies pay providers there.